Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study
Authors
Claire Roger (ORCID: https://orcid.org/0000-0002-6055-0034)
Jan J. De Waele (ORCID: https://orcid.org/0000-0003-1017-9748)
María Patricia Hernández-Mitre (ORCID: https://orcid.org/0000-0003-3565-0292)
João Pedro Baptista (ORCID: https://orcid.org/0000-0002-6790-806X)
Monica A. Slavin (ORCID: https://orcid.org/0000-0002-8443-314X)
Mohd Basri Mat Nor (ORCID: https://orcid.org/0000-0002-5433-6357)
Jason A. Roberts (ORCID: https://orcid.org/0000-0001-6218-435X)
European Society of Clinical Microbiology and Infectious Diseases
University of Queensland
Fonds Wetenschappelijk Onderzoek
Vlaamse regering
Medical Research Council
National Health and Medical Research Council
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study
Claire Roger, Jan J. De Waele, María Patricia Hernández-Mitre, João Pedro Baptista et al.
Citations
28 citations
Journal
Intensive Care Medicine
Topics
Antifungal resistance and susceptibility
Field-Weighted Citation Impact (FWCI)
39.09
article
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study
Claire Roger, Jan J. De Waele, María Patricia Hernández-Mitre, João Pedro Baptista, Monica A. Slavin, Mohd Basri Mat Nor, Jason A. Roberts, Giancarlo Ceccarelli, Markus Zeitlinger, Jordi Rello, Roger J. M. Brüggemann, Fekade B. Sime, Leonardo Seoane, Jeffrey Lipman, George Dimοpoulos, Jean‐Yves Lefrant, Mario Venditti, Jai N. Darvall, Miia Valkonen, Wai Tat Wong
article en
28 citations
Abstract
No abstract available for this paper.
Publication Tag
Intensive Care MedicineVol. 51(2)
Institutions
Queensland Health (AU), The Royal Melbourne Hospital (AU), Ochsner Health System (US), University of Helsinki (FI), Radboud University Nijmegen (NL), The University of Queensland (AU), The University of Melbourne (AU), Chinese University of Hong Kong (HK), University of New Orleans (US), Université de Montpellier (FR), National and Kapodistrian University of Athens (GR), Royal Brisbane and Women's Hospital (AU), Ochsner Medical Center (US), Policlinico Umberto I (IT), Helsinki University Hospital (FI), Peter MacCallum Cancer Centre (AU), Ghent University Hospital (BE), Instituto de Salud Carlos III (ES), Hospitais da Universidade de Coimbra (PT), Radboud University Medical Center (NL), Ghent University (BE), International Islamic University Malaysia (MY), Metro South Health (AU), Centre Hospitalier Universitaire de Montpellier (FR), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Vall d'Hebron Institut de Recerca (ES), Centre Hospitalier Universitaire de Nîmes (FR), Radboud Institute for Molecular Life Sciences (NL), Université de Nîmes (FR), Medical University of Vienna (AT)
Funders
Gilead Sciences, Royal Brisbane and Women's Hospital Foundation, European Society of Clinical Microbiology and Infectious Diseases, University of Queensland, Fonds Wetenschappelijk Onderzoek, Vlaamse regering, Medical Research Council, National Health and Medical Research Council